David Rolfe - Wedgewood Partners
Holding/activity history for Gilead Sciences (GILD)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2014 Q2 | 0 | 0 | Sell 100.00% | 2.50 | |
| 2014 Q1 | 1,907,287 | 2.50 | Add 5.90% | 0.14 | $70.86 |
| 2013 Q4 | 1,800,984 | 2.81 | Reduce 28.36% | 1.11 | $75.10 |
| 2013 Q3 | 2,513,914 | 3.79 | Add 2.21% | 0.08 | $62.87 |
| 2013 Q2 | 2,459,512 | 3.64 | Add 9.22% | 0.31 | $51.27 |
| 2013 Q1 | 2,251,933 | 3.78 | Reduce 3.03% | 0.12 | $48.94 |
| 2012 Q4 | 2,322,218 | 3.95 | Add 29.15% | 0.89 | $36.72 |
| 2012 Q3 | 1,798,118 | 3.80 | Reduce 29.49% | 1.59 | $33.17 |
| 2012 Q2 | 2,550,024 | 5.03 | Add 6.56% | 0.31 | $25.64 |
| 2012 Q1 | 2,393,054 | 4.73 | Reduce 1.44% | 0.07 | $24.43 |
| 2011 Q4 | 2,427,910 | 6.06 | $20.46 |